Armata Pharmaceuticals (ARMP) Assets Growth (3y) (2016 - 2026)
Armata Pharmaceuticals (ARMP) Assets Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.75% |
| Dec 31, 2025 | -7.08% |
| Sep 30, 2025 | -1.22% |
| Jun 30, 2025 | -7.17% |
| Mar 31, 2025 | -6.80% |
| Dec 31, 2024 | 7.40% |
| Sep 30, 2024 | 32.04% |
| Jun 30, 2024 | 30.91% |
| Mar 31, 2024 | 31.57% |
| Dec 31, 2023 | 35.53% |
| Sep 30, 2023 | 35.15% |
| Jun 30, 2023 | 26.96% |
| Mar 31, 2023 | 35.11% |
| Dec 31, 2022 | 55.57% |
| Sep 30, 2022 | 46.89% |
| Jun 30, 2022 | 42.48% |
| Mar 31, 2022 | 123.78% |
| Dec 31, 2021 | 68.65% |
| Sep 30, 2021 | 58.98% |
| Jun 30, 2021 | 60.31% |